Effects of Gender and Age at Diagnosis on Disease Progression in Long-term Survivors of Cystic Fibrosis-Reference-Cited by-同舟云学术

Effects of Gender and Age at Diagnosis on Disease Progression in Long-term Survivors of Cystic Fibrosis

Published:2010-09 Issue:5 Volume:182 Page:614-626
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Nick Jerry A.,Chacon Cathy S.,Brayshaw Sara J.,Jones Marion C.,Barboa Christine M.,Clair Connie G. St.,Young Robert L.,Nichols David P.,Janssen Jennifer S.,Huitt Gwen A.,Iseman Michael D.,Daley Charles L.,Taylor-Cousar Jennifer L.,Accurso Frank J.,Saavedra Milene T.,Sontag Marci K.

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference76 articles.

1. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes

2. An international/multicentre report on patients with cystic fibrosis (CF) over the age of 40 years

3. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB,et al.Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.J Pediatr2008;153:S4–S14.

4. Nonclassic cystic fibrosis and CFTR-related diseases

5. A Novel Mutation in the Cystic Fibrosis Gene in Patients with Pulmonary Disease but Normal Sweat Chloride Concentrations

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex differences in airway disease: estrogen and airway surface liquid dynamics;Biology of Sex Differences;2024-07-18

2. Characteristics of individuals with cystic fibrosis in the United States ineligible for ivacaftor and elexacaftor/tezacaftor/ivacaftor;Journal of Cystic Fibrosis;2024-07

3. ECFS standards of care on CFTR-related disorders: Identification and care of the disorders;Journal of Cystic Fibrosis;2024-07

4. MODELING CYSTIC FIBROSIS PATIENT PROGNOSIS: NOMOGRAMS TO PREDICT LUNG TRANSPLANTATION AND SURVIVAL PRIOR TO HIGHLY EFFECTIVE MODULATOR THERAPY;2023-09-26

5. Cystic fibrosis-related mortality in the United States from 1999 to 2020: an observational analysis of time trends and disparities;Scientific Reports;2023-09-12